The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

Paul K. Whelton(Tulane University), Pat Kennedy, William B. Applegate(Wake Forest University), Frank M. Sacks(Unknown), Lyn M. Steffen(University of Minnesota), Arlene Dalcin, Lawrence J. Appel(Korea Advanced Institute of Science and Technology), Martha Clare Morris(Rush University Medical Center), Neil B. Rappaport, Ellen O’Connor, David M. Batey, Denis A. Evans(Rush University Medical Center), James M. Raczynski(University of Alabama at Birmingham), Jeanne Charleston, Laretha Goodwin, Stephen T. Miller(Princeton University), Linda P. Fried(Unknown), Wade Lovelace(Allogene Therapeutics (United States)), Shiriki Kumanyika(Drexel University), Heidi Hataway, Sheila J. Hamill, Beth Walker Corkery, Karen Counts, Doug Heustis, Eleanor Pistorino, Delores Kaidy, Lee Dolan, Joe Murphy, Marshall Lee, Albert Oberman(Tulane University), W. Gordon Walker(Tulane University), L. M. Peel, Norman L. Lasser(University at Buffalo, State University of New York), Andrew C. Ertl, Roland L. Weinsier, Mary Ellen Keough, Mary Cameron, Nancy King Wright, Judy Randle, Amy Brewer, E. M. Bernauer, Nemat O. Borhani, Jay M. Sullivan, James O. Taylor, Sheila A. Corrigan, Michael J. Klag(Johns Hopkins University), Craig K. Ewart, Patricia Borhani, Carolyn Sugars
JAMA
March 4, 1992
Cited by 121


Related Papers